ADHD & Neurodevelopmental
Adolescents & Adults
Attention-Deficit/Hyperactivity Disorder (ADHD) impacts focus, behavior regulation, academic performance, and daily functioning across all age groups. CenExel partners with sponsors to accelerate innovative ADHD treatments through specialized clinical research, experienced investigators, and access to diverse patient populations.
Leading ADHD Clinical Research Solutions
CenExel delivers comprehensive ADHD clinical trial support across pediatric, adolescent, and adult populations. Our experienced research teams specialize in behavioral health assessments, patient recruitment, cognitive evaluations, and protocol-driven study execution to ensure high-quality data and participant care.
Accelerated Enrollment
Experienced Behavioral Health Teams
ADHD & Related Conditions We Research
Our ADHD research programs support a wide range of neurodevelopmental and behavioral conditions across pediatric and adult populations.
- ADHD – Pediatric
- ADHD – Adult
- ADHD with Anxiety
- ADHD with Depression
- Oppositional Defiant Disorder (ODD)
- Autism Spectrum Disorder (ASD)
- Conduct Disorder
- Behavioral Dysregulation
Why Sponsors Choose CenExel for ADHD Research
CenExel combines scientific expertise, rapid enrollment capabilities, and specialized behavioral health infrastructure to support successful ADHD clinical trials.
01
Specialized ADHD Recruitment
Targeted outreach strategies connect sponsors with pediatric, adolescent, and adult ADHD populations efficiently.
02
Neurobehavioral Expertise
Our experienced investigators support complex ADHD protocols, cognitive assessments, and behavioral endpoints.
03
Diverse Patient Access
Our nationwide site network provides access to diverse demographic populations across multiple regions.
04
High Retention Rates
Patient-focused engagement strategies help improve compliance, retention, and study continuity.
Supported ADHD Trial Phases
CenExel supports early- and late-phase ADHD clinical research, from first-in-human studies through post-marketing observational research.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Our behavioral health research infrastructure supports cognitive testing, patient-reported outcomes, digital endpoints, and long-term ADHD treatment evaluations.
ADHD Task Force
CenExel supports ADHD and neurodevelopmental clinical trials with experienced investigators, centralized recruitment strategies, and specialized behavioral health expertise.






